Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 1999, p. 7481-7490, Vol. 19, No. 11
Institute of Genetics, University of
Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom
Received 15 March 1999/Returned for modification 13 May
1999/Accepted 6 August 1999
We have analyzed the in vivo importance of different regions of
Rap1p, a yeast transcriptional regulator and telomere binding protein.
A yeast strain (SCR101) containing a regulatable RAP1 gene
was used to test functional complementation by a range of Rap1p
derivatives. These experiments demonstrated that the C terminus of the
protein, containing the putative transcriptional activation domain and
the regions involved in silencing and telomere function, is not
absolutely essential for cell growth, a result confirmed by sporulation
of a diploid strain containing a C terminal deletion derivative of
RAP1. Northern analysis with cells that expressed Rap1p
lacking the transcriptional activation domain revealed that this region
is important for the expression of only a subset of Rap1p-activated
genes. The one essential region within Rap1p is the DNA binding domain.
We have investigated the possibility that this region has additional
functions. It contains two Myb-like subdomains separated by a linker
region. Individual point mutations in the linker region had no effect
on Rap1p function, although deletion of the region abolished cell
growth. The second Myb-like subdomain contains a large unstructured
loop of unknown function. Domain swap experiments with combinations of
elements from DNA binding domains of Rap1p homologues from different
yeasts revealed that major changes can be made to the amino acid
composition of this region without affecting Rap1p function.
Rap1p is a yeast multifunctional
protein involved in transcriptional activation, transcriptional
silencing, and telomere function (13, 29, 30, 34, 35, 46,
47). It has a complicated organization with several apparently
independent functional domains. The 827-amino-acid primary sequence can
be subdivided conveniently into three regions, a central DNA binding
domain plus N-terminal and C-terminal domains of approximately equal
size (46). The DNA binding domain is located between amino
acids 361 and 596 and consists of two Myb-like subdomains, each based
on a helix-turn-helix motif (24, 27). The first subdomain
(domain 1) contains three alpha helices, the second and third of which
comprise the helix-turn-helix motif (H1B and H1C). The second subdomain
(domain 2) contains four alpha helices; again, the second and third
helices form a helix-turn-helix motif (H2B and H2C). In each subdomain,
the third helix is the DNA recognition helix and the other helices are
important in maintaining the overall architecture of the structure
(27). The two subdomains are connected by a linker of
approximately 30 amino acids that may be important in determining their
relative positions. This linker contains two turns, each composed of
six amino acids. An additional feature of interest in the second
subdomain is a relatively large region of more than 50 amino acids that has been described as a partially unstructured loop. This is located between helices 2A and 2B, and its function, if any, is not apparent (27). The C terminus of Rap1p contains regions implicated in transcriptional activation (positions 630 to 695), as well as mating
type and telomeric silencing and telomeric length control (positions
665 to 827) (20, 30, 32, 49). It is also important for the
mechanism that results in transcriptional repression of ribosomal
protein genes when there is a defect in the protein secretion pathway
(37). The C terminus is the target for all of the
protein-protein interactions involving Rap1p characterized to date,
including interactions with the Sir proteins Sir3p and Sir4p and
competing interactions with the Rif proteins Rif1p and Rif2p (21,
23, 38, 53). The N terminus of Rap1p is a large region that is
not essential for cell viability, although it may be involved in
regulating the activity of Rap1p through a putative BRCT domain
(6, 38). It has also been shown to potentiate DNA bending by
Rap1p in vitro (39).
Rap1p has been implicated in transcriptional activation of many genes,
including the mating-type genes MAT To gain more insights into the activation role of Rap1p, we have
undertaken a detailed functional analysis of the protein in vivo. Our
aim was to define the regions of Rap1p that are required for cell
survival, based on the premise that the transcriptional activation
function is likely to be essential. In the second part of the analysis,
we used Rap1p homologues from other yeast species. Studies of
homologues of important proteins from related organisms often reveal
key information about their functional organization. The only homologue
of Rap1p characterized to date was identified in Kluyveromyces
lactis (31). This protein is smaller than the budding
yeast protein, largely because the N-terminal domain is reduced in
size. The DNA binding domain is relatively highly conserved (69%
identity), as are other regions within the C-terminal domain. The
K. lactis protein does not provide the essential function or
functions of budding-yeast Rap1p in complementation experiments (31). Homologues of Rap1p appear to be present in other
budding yeasts (42), and we have recently used degenerate
PCR to clone DNA fragments encoding the DNA binding domains of two such
homologues (see Results). There is also a partial sequence encoding a
putative Rap1p homologue in the Candida albicans genome
database (Stanford University). We have used these sequences in
combination with the crystal structure of the Saccharomyces
cerevisiae DNA binding domain to investigate further the functions
of the DNA binding domain of Rap1p.
Strains and media.
Plasmid manipulations were carried out
with Escherichia coli MC1061 [F Plasmid construction.
A fragment of the RAP1 gene
(positions
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
In Vivo Analysis of Functional Regions within
Yeast Rap1p


![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1 and
MAT
2, ribosomal protein genes, and glycolytic genes
(3-5, 10, 16, 40, 43, 44, 54). At the MAT
locus, the MAT
1 and MAT
2 genes are activated by a bidirectional upstream activation sequence (UAS) consisting of a single Rap1p site (16). UAS found upstream
of some of the ribosomal protein genes are more complex, containing one
or more Rap1p binding sites and a T-rich DNA element approximately 25 bp in length (17, 18, 43, 54). A third class of Rap1p UAS
are found upstream of many glycolytic genes. These contain binding
sites for several other transcription factors, including Gcr1p, a
glycolytic gene-specific factor (1, 12, 26). It is possible
that Rap1p performs a single function at these diverse UAS or that it
works in different ways in the different situations. The current view
in the literature is that Rap1p contains a single transcriptional
activation domain analogous to conventional transcription factors
(20, 38, 46). At the simple MAT
UAS, Rap1p may make direct contact with the general transcriptional machinery via this
activation domain. However, at the more complex UAS, it may not work in
this way. At the UAS of the HIS4 gene, a Rap1p binding site
is required for both basal transcription and stimulated transcription
in response to amino acid starvation (14). It must be
present for the formation of micrococcal nuclease-sensitive regions
corresponding to binding sites for the transcriptional activators
Gcn4p, Bas1p, and Bas2p (14). The role of Rap1p in this
situation may be to modify the chromatin structure around its binding
site to allow other transcription factors access to the DNA. The idea
that Rap1p is an accessory factor that facilitates the roles of other
activators has been supported by studies on the promoters of ribosomal
protein genes, although these do not provide evidence that chromatin
effects are important. At these promoters, although a single Rap1p site
on its own can activate transcription, significantly greater effects
are seen when it is combined with a T-rich element, which on its own is
also a poor activator (17). At the UAS of the glycolytic
genes ENO1, TPI, and PYK1, Rap1p
functions to promote the binding of Gcr1p, a protein that interacts
with DNA only very weakly on its own (2, 15, 52). This could
be achieved via a direct protein-protein interaction or by some effect
of Rap1p on the surrounding DNA (44, 51). There may also be
some redundancy of function within the N- and C-terminal domains of
Rap1p because it can promote DNA binding by Gcr1p in vitro as long as
the DNA binding domain plus either the N terminus or the C terminus is
present (33).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
araD139
(ara-leu)7696
(lac)174 galU galK hsdR strA
(Strr)]. Rap1p derivatives were analyzed in the
conditional rap1 strain SCR101 (18) grown in
synthetic complete (SC) medium (22) containing either 2%
(wt/vol) galactose or 2% (wt/vol) glucose, supplemented with 0.2%
(wt/vol) adenine, tryptophan, and histidine. The rap1
C strains were constructed with the diploid strain 842 a/
ade2-1/ade2-1 trp1-1/trp1-1 leu2/leu2 his3-11/his3-11 ura3/ura3 can1/CAN1. Zygosaccharomyces rouxii NCYC 564 and
Saccharomyces unisporus NCYC 971 were obtained from the
National Collection of Yeast Cultures, Norwich, United Kingdom.
436 to +1809) was amplified by PCR (primers U/S1 and U/S2
[Table 1]) to introduce novel
BglII sites at positions
429 and +1799 and a
SmaI site at position +1793. This PCR product was cut with
BglII and cloned into the BamHI site of pRS415
(48) to generate pAJ826. A SphI-SalI fragment of pPE711 (10) was inserted into pAJ826 to
regenerate the entire 3' end of the RAP1 gene (pRAP1).
Plasmid pRAP
C was constructed by the insertion of a blunt-ended
BglII-EcoRI fragment containing the
PGK terminator fragment (36) into the
SmaI site of pAJ826. pRAP
N
C and pRAP
N were made by
deleting the region between the two NsiI sites in the
RAP1 gene (positions +52 to +1024) from pRAP
C and pRAP1,
respectively. A fragment of the RAP1 gene from positions
+1033 to +1902 was amplified by PCR (primers 1797+ and 2666
) to
introduce a novel HindIII site at position +1891. This
PCR product was cleaved with HindIII and used to replace the
HindIII fragment of pRAP1 (positions +1080 to +2074),
deleting positions +1891 to +2074 (pRAP
Act). To construct
pRAP
Sil, a BclI fragment of pRAP1 (positions +1203 to
+2395) was replaced with a BclI-BglII fragment
(positions +1203 to +2101) from pPE711. pRAP
Tox was made by PCR
amplification of a region of the RAP1 gene from positions
+1876 to +2497 (primers 2640+ and 3262
), introducing a novel
BamHI site at position +1886. This PCR product was cloned
into pGEM T (Promega) and reisolated as a
BamHI-SalI fragment. This was blunt ended and
subcloned into the SmaI site of pAJ826, thus deleting
positions +1793 to +1885 from the RAP1 sequence. A 902-bp
HindIII fragment of this construct was used to replace
the 994-bp HindIII fragment from the wild-type
RAP1 gene in pRAP1, giving pRAP
Tox. Plasmid pAJ90, used
to generate the rap1
C strain, was constructed as follows.
A URA3 selectable marker was isolated as a
HindIII-SmaI fragment from plasmid
pYEUra3 (Clontech), and the HindIII end was made
blunt. The resulting fragment was cloned into an end-filled
XbaI site (422 bp downstream of the stop codon of
RAP1) in the downstream region of the RAP1 gene.
PCR was then used to amplify the region between the stop codon of
RAP1 and position +1001, containing the URA3
gene, incorporating SmaI sites at both ends of the fragment
(primers RDSF and RDSR2). The PCR product was cut with SmaI
and ligated into SmaI-digested pAJ826. This introduced a DNA
sequence encoding 4 amino acids (TRDE) and a stop codon immediately
downstream of the region encoding the DNA binding domain of Rap1p
followed by the RAP1 downstream region containing the
selectable marker.
TABLE 1.
Synthetic oligonucleotides used in this study
or 662
. These primers introduced
SmaI sites at both ends of the PCR product. Each product was
cut with SmaI before being ligated into pAJ94. The resulting
plasmids encoded Rap1p in which amino acid 597 had been changed to a
threonine residue; this was followed by the required amino acids from
Rap1p plus the amino acids RDE and a stop codon.
Generation of the RAP1/rap1
C strains.
A
HindIII fragment of pAJ90 encoding the DNA binding
domain of Rap1p and also containing the RAP1 downstream
region plus the URA3 selectable marker was transformed into
the diploid strain 842 by the one-step method (11). Plasmids
pAJ96 and pAJ97 were digested with BamHI and
EcoRI to produce similar fragments for transformation.
Transformants were selected on SC medium lacking uracil. Colonies that
grew were screened for the required gene replacement by using gel
retardation assays and Southern blotting.
Generation of specific mutations in the DNA binding domain of
Rap1p.
Site-specific mutations were introduced into the
RAP1 gene by using the QuikChange site-specific mutagenesis
kit as specified by the manufacturer (Stratagene). Primers pRH1 and
pRH2 were used to create the D422N mutation, and primers pRH3 and pRH4
were used to create the K423A mutation. To delete the linker region
from the DNA binding domain, two fragments of the RAP1 gene
(positions +1033 to +1274 and positions +1291 to +2102) were amplified
by PCR (with primers 1797+, pRH5, pRH6, and AD695
), such that a novel
SalI site was introduced into each fragment (positions +1263 and +1301). Both fragments were digested with SalI and
ligated to create a larger RAP1 fragment. This fragment was
digested with HindIII and used to replace the
corresponding HindIII fragment of pRAP1. The resulting
plasmid encoded Rap1p lacking the two short turns within the DNA
binding domain.
Construction of hybrid DNA binding domain expression
plasmids.
The RAP1 promoter and coding region
(positions
429 to +2709) was isolated as a
NotI-SalI fragment from pRAP1 and cloned into the
corresponding sites of plasmid pRS413 (48) to create pAJ928. A silent point mutation (A to G) was introduced at position +1332 in
the RAP1 gene by using the QuikChange kit (primers pRH7 and pRH8). This mutation created a ClaI site (position +1331)
upstream of helix H2A of the DNA binding domain. This plasmid, pAJ930, also contained novel SphI and SmaI sites at
positions +1601 and +1793, respectively, within the RAP1
gene. Plasmid pAJ930 was used to create the hybrid DNA binding domain
expression plasmids. Fragments of the RAP1 genes encoding
the three different unstructured loop regions flanked by helices H2A
and H2B were generated by PCR. The K. lactis sequence was
isolated with primers pRHKL1 and pRHKL2, the S. unisporus
sequence was isolated with primers pRHSUZR and pRHSU2, and the Z. rouxii sequence was isolated with primers pRHSUZR and pRHZR2. The
RAP1 fragments were digested with ClaI and
SphI and cloned into the corresponding sites in pAJ930. The region of the K. lactis RAP1 gene encoding subdomain 2 was
generated by PCR with primers pRHKL1 and pRHKL4, digested with
ClaI and SmaI, and cloned into the corresponding
sites of pAJ930.
Isolation of RAP1 homologues by degenerate PCR. Yeast genomic DNA prepared by the "ten minute" method (25) was subjected to PCR with degenerate primers homologous to conserved regions within the DNA binding domain of S. cerevisiae and K. lactis Rap1p. Primer 1 corresponds to the amino acid sequence EEDEFILD (amino acids 366 to 373 in S. cerevisiae Rap1p) and contained the degenerate DNA sequence 5'GARGARGAYGARTTYATHYTNGA 3' (N = A, C, G, or T; K = G or T; R = A or G; Y = C or T; H = A, C, or T). Primer 2 was the reverse complement of the amino acid sequence ENAWRDRF (amino acids 538 to 545 in S. cerevisiae Rap1p) and contained the degenerate DNA sequence 5' AANCKRTCCKCCANGCRTTYTC 3'. PCR with successively lower annealing temperatures in the initial cycles (touchdown PCR) was used for 35 cycles of 94°C for 1 min, annealing at 70°C initially and then a decrease of 2°C every two cycles to a final temperature of 56°C, and extension at 72°C for 2 min 30 s.
Complementation of conditional rap1 strains. SCR101 cells were transformed with each of the RAP1-containing plasmids by the one-step method (11). Transformants were selected and restreaked on SC agar containing galactose. For colony dilution assays, transformed cells were suspended in 0.5 ml of 25 mM sodium phosphate buffer (pH 7), and serial dilutions containing 106, 105, 104, and 103 cells/ml were made. Aliquots of each dilution (10 µl) were spotted onto SC plates containing glucose or galactose. Growth was carried out for 4 days at 30°C. Growth curves were generated by inoculating transformants at a cell density of 104 per ml into SC medium containing glucose and taking optical density readings at 600 nm.
Isolation of probes used in Northern analysis.
PCR was
performed on total yeast genomic DNA isolated from S. cerevisiae LL20 (NCYC 1445), using primers specific for the following loci: PYK1 (positions +292 to +771),
MAT
1 (+91 to +490), MAT
2 (+34 to +600),
RPS10 (+491 to +950), RPL19 (+425 to +919), and
RPL45 (+30 to +314). The PGK mRNA and 18S rRNA
probes have been described previously (8).
Northern analysis. Transformed SCR101 cells were grown for approximately six generations (to a cell density of 107 cells per ml) in SC medium containing glucose. Total cellular RNA was extracted from 20 ml of each culture by using the PureScript system (Gentra Systems, Inc.). A 10-µg portion of each RNA sample was electrophoresed through a 1.5% agarose gel containing 20 mM morpholinepropanesulfonic acid (MOPS), 5 mM sodium acetate, 0.1 mM EDTA, and 0.66 M formaldehyde. The separated RNA samples were then transferred to Zeta Probe GT nylon membrane (Bio-Rad Laboratories Ltd.) and probed with radioactively labelled fragments of the relevant genes. Probes were removed from the membrane by soaking in 0.1× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% sodium dodecyl sulfate at 95°C prior to subsequent probings. The signals from each probe were quantified with a Molecular Dynamics PhosphorImager and compensated for background. After adjusting the figures for differences in loading, the RNA level in the RAP1+ strain was designated 100% and the RNA levels in the other strains were calculated relative to this percentage.
Production of Rap1p derivatives by in vitro transcription and translation. All Rap1p mutants were prepared by in vitro transcription-translation with the TNT reagents as specified by the manufacturer (Promega). Control templates were used to produce either the isolated DNA binding domain of Rap1p or the full-length protein. Reaction mixtures containing no added DNA template were used in parallel.
Gel retardation assays. SCR101 transformants were grown to mid-log phase in SC medium containing glucose, and total protein extracts were made as described previously (19). Gel retardation assays were performed with 2 µg of total protein extract and probes specific for Rap1p and for Abf1p, as described previously (9). Sites 1 and 2 in Fig. 6 were two weak Rap1p binding sites isolated previously (19). Site 1 contained the sequence 5'CGTACACCCACCAGAT3', and site 2 contained the sequence 5'GAGCCTAACACCC3'.
Western blotting. Aliquots (10 µg) of each total protein extract were electrophoresed in a 10% polyacrylamide gel containing sodium dodecyl sulfate, then transferred to 0.2-µm-pore-size nitrocellulose. The filter was blocked in 2.5% (wt/vol) dried milk powder-0.05% (vol/vol) lauryl dimethylamine oxide (LDAO) in Tris-buffered saline (buffer I). Rabbit anti-Rap1p antibody (generously provided by Judith Berman) was used at a 1:5,000 dilution in buffer I, and the filter was washed for three periods of 30 min in buffer I. The secondary antibody used was horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G at a dilution of 1:2000 in buffer I. The filter was washed three times in Tris-buffered saline, prior to detection using the enhanced chemiluminescence system (Amersham), according to the manufacturer's instructions.
Nucleotide sequence accession numbers. The GenBank accession numbers for the cloned S. unisporus and Z. rouxii sequences are AF043217 and AF043218, respectively.
| |
RESULTS |
|---|
|
|
|---|
Analysis of N-terminal and C-terminal deletions.
To
investigate the in vivo importance of different regions of Rap1p, we
used yeast strain SCR101 (18). In this strain the chromosomal copy of the RAP1 gene is under the control of
the GAL UAS, allowing Rap1p expression to be turned on and
off by growing yeast cells on minimal medium containing either
galactose (gal medium) or glucose (glu medium). The ability of a series of Rap1p derivatives to allow the growth of SCR101 in the absence of
endogenous Rap1p has been determined. Each derivative was expressed from the authentic RAP1 promoter on a single-copy plasmid.
Transformants were selected on gal medium (chromosomal RAP1
gene on) and then plated at a series of dilutions on glu medium (Fig.
1A). Transformants containing either the
positive or negative control plasmid (pRS415 and pRAP1) behaved as
expected. The other plasmids expressed Rap1p derivatives lacking
defined regions of the N and/or C terminus. To confirm that the
approach generated results consistent with previous work from other
laboratories, these included regions thought to be nonessential for
Rap1p function. For example, pRAP
N expressed Rap1p lacking most of
the N terminus (amino acids 19 to 340), a region thought not to be
required for normal growth (38). Our results confirmed this
observation. The C terminus of Rap1p contains regions of the protein
implicated in transcriptional activation, silencing, and telomere
length regulation and is the target for interactions with Rif1p, Rif2p,
Sir3p, and Sir4p (20, 21, 32, 38, 49, 53). We found that
deletion of either the transcriptional activation domain (pRAP
Act,
deletion of amino acids 629 to 690) or the C-terminal silencing domain
(pRAP
Sil, deletion of amino acids 700 to 798) resulted in a
slow-growth phenotype but was not lethal. The slow-growth phenotype of
cells expressing these deletion derivatives is consistent with the
behavior of yeast strains containing the rap1t
alleles, which truncate the protein within the C terminus
(30). When the entire C terminus of the protein was
absent (pRAP
C), either alone or in combination with a deletion
within the N terminus (pRAP
N
C), growth was compromised even
further and only microcolonies were produced. A deletion that removed
most of the N terminus of the protein and approximately half of the DNA
binding domain (pRAP
DBD; deletion of amino acids 20 to 497)
completely abolished the ability of the cells to grow.
|
N, or Rap1p
Tox (deletion of amino acids 597 to 629)
exhibited very similar growth characteristics whereas cells expressing
Rap1p
Act or Rap1p
Sil showed slower growth during the exponential
phase. The remaining Rap1p derivatives resulted in even slower growth
which was difficult to quantify because prolonged growth in liquid
culture selected cells in which recombination between the chromosomal
and plasmid-borne RAP1 genes had occurred (data not shown).
To establish that the Rap1p derivatives were produced correctly and
were the only source of Rap1p in cells growing in glucose medium,
protein extracts were prepared from mid-log-phase cultures and tested
in Western blots with an anti-Rap1p antibody (Fig. 1C). The
transformants expressing full-length Rap1p, Rap1p
Tox, Rap1p
C,
Rap1p
Sil, and Rap1p
Act each contained a Rap1p derivative of the
predicted size. Rap1p
N
C was not detected by the assay, probably
because this derivative lacked the epitopes recognized by the antibody.
The presence of this protein was confirmed by a gel retardation assay
with the strong Rap1p binding site from the TEF2 promoter as
a probe (data not shown).
Generation of a rap1
C haploid strain.
To
confirm the observation that the C terminus of Rap1p is not essential
for cell growth, we constructed a rap1
C haploid strain by
sporulation of a heterozygous diploid. One copy of the RAP1
gene in the diploid strain was replaced with a deleted version that
lacks the region encoding the entire C terminus of Rap1p. This diploid
strain produced the full-length and deleted versions of Rap1p in
approximately equal amounts as judged by gel retardation assays (data
not shown). The strain was then sporulated, and tetrads were dissected
onto yeast extract-peptone-dextrose (YPD) medium. This resulted in a
2:2 segregation of normally growing and very-slow-growing colonies. The
very-slow-growing colonies became visible to the naked eye only after
about 10 days of incubation at 30°C. However, the development of
individual colonies could be observed microscopically, and it was clear
that the cells were surviving and dividing at a very low but constant
rate (Fig. 2). This confirmed the
observation from the SCR101 experiments that the C terminus of Rap1p is
important for normal growth but is not absolutely essential.
|
Where is the key region for cell growth in the C terminus of
Rap1p?
The rap1
C strain grew very slowly, with
dissected spores giving visible colonies only after 10 days of
incubation at 30°C (see above). This is significantly poorer growth
than that observed previously for a strain containing the
rap1-17 allele, one of the rap1t
alleles that encodes a derivative of Rap1p truncated at amino acid 662, approximately halfway through the activation domain (30). To
test which region in the C terminus of Rap1p is responsible for this
difference in growth, we constructed two new haploid strains. The first
of these expressed a Rap1p derivative truncated at amino acid 662 (rap1
C/662) and is similar to the rap1-17
strain. The second expressed a Rap1p derivative truncated at amino acid 628 (rap1
C/628). This strain lacked the entire activation
domain but contained the region between amino acids 598 and 628. Spores containing each of these rap1 alleles were dissected onto
YPD medium, and their growth was compared with that of isogenic
wild-type spores and of spores containing Rap1p lacking the entire C
terminus (Fig. 2C). The rap1
C/662 spores produced
colonies that grew more slowly than the wild type but significantly
faster than the rap1
C spores, which, after only 5 days of
growth, have not given rise to visible colonies. This result is
consistent with previously published data (30). The
rap1
C/628 spores gave rise to colonies that were clearly
visible after 5 days but were much smaller than the
rap1
C/662 colonies. Each of the truncated proteins was
present at approximately the same level in transformed cells (data not shown). These results suggest that the main reason for the growth rate
difference between rap1-17 and rap1
C strains
is the presence or absence of the region between amino acids 629 and
662. They also suggest that in the absence of the rest of the C
terminus, the region between amino acids 598 and 628 may play a
functional role.
Differential effects of activation domain and
silencing-domain deletions on transcription of diverse
genes.
Because SCR101 transformants expressing either Rap1p
Sil
or Rap1p
Act grew at reasonable rates in liquid culture, it was
possible to investigate the effects of these deletions on the
expression of Rap1p-activated genes (Fig.
3 and Table
2). At the MAT
locus, the
results were not identical for MAT
1 and
MAT
2, although they are activated by a single
bidirectional UAS (16). In the Rap1p
Act strain,
expression of MAT
1 was reduced by more than 50% whereas expression of MAT
2 showed little change. Expression of
both MAT
genes was increased in the Rap1p
Sil strain
(see Discussion). RPL19A and RPL19B are two
ribosomal protein genes located on chromosome II that encode identical
proteins. Each gene has a promoter containing a Rap1p binding site and
a T-stretch. We compared the expression of these genes with the
expression of RPL45, a ribosomal protein gene activated by
Abf1p (18). RPL19 and RPL45 mRNA
levels both increased in the Rap1p deletion strains, suggesting that
these ribosomal protein genes can respond to secondary consequences of
the Rap1p deletions. Although this complicates the interpretation of
the data, the results show clearly that the activation domain of Rap1p
is not absolutely required for expression of RPL19. Similar experiments with a second pair of ribosomal protein genes with the
Rap1p binding site plus T-stretch promoter organization,
RPS10-1 and RPS10-2 (43), gave similar
results (data not shown), suggesting that the results for
RPL19 are typical of this class of genes. Finally, we
determined the effects of the RAP1 deletions on expression of two glycolytic genes, PGK and PYK1. These
genes have UAS that are complex and contain binding sites for several
different transcription factors, including Rap1p (7-10, 15,
40). In both Rap1p
Sil and Rap1p
Act strains, PGK
expression was reduced by over 80%. PYK1 expression showed
little change in the Rap1p
Sil strain and a small decrease in the
Rap1p
Act strain.
|
|
Analysis of conserved regions within the DNA binding domain. Because the DNA binding domain is the only essential region within Rap1p, we considered the possibility that it has extra functions in addition to DNA recognition. To investigate this, we isolated sequences encoding DNA binding domains of RAP1 homologues from other yeasts and used these in a functional analysis. Degenerate PCR was used to clone genomic DNA fragments from the yeasts Z. rouxii and S. unisporus that encode DNA binding domains of putative Rap1p homologues. We compared the amino acid sequences encoded by these fragments with the DNA binding domains of S. cerevisiae and K. lactis Rap1p and with the same region from a putative C. albicans Rap1p homologue described in the C. albicans genome database (Fig. 4). The Rap1p DNA binding domain is well conserved between the homologues with the highest degree of conservation in domain 1. The double-turn region separating the two subdomains is also generally well conserved, although in the C. albicans protein the first turn differs to some extent. The unstructured loop shows less conservation in sequence but is conserved in length, except for in the putative C. albicans Rap1p, which has 44 amino acids fewer than the other proteins in this region.
|
In vitro and in vivo effects of mutagenesis of the double-turn region. In our functional analysis of the DNA binding domain, we focused on the regions that are not involved directly in binding to DNA. Specific conserved amino acids in the double-turn motif within the linker region of the S. cerevisiae Rap1p were subjected to site-directed mutagenesis. The first turn in all the Rap1p homologues starts with an aspartic acid residue (D422). This was changed to an asparagine. The crystal structure of the Rap1p DNA binding domain suggested that the second amino acid in the first turn (lysine, K423) could be at a key position if the double-turn region is involved in protein-protein interactions (27). To investigate this possibility, the lysine was mutated to an alanine. To test the effects of these mutations on the function of Rap1p in vivo, each mutation was introduced into the full-length RAP1 gene. The ability of each mutant protein to provide the essential function(s) of Rap1p was determined by using complementation in yeast strain SCR101 (Fig. 5A). Transformants containing either mutant protein grew normally on glu medium, suggesting that neither mutation had affected any essential function mediated through the DNA binding domain. Gel retardation assays with each of the mutant DNA binding domains produced in vitro demonstrated that neither mutation had affected the ability of Rap1p to bind to DNA (data not shown).
|
423-435). This was predicted to
result in the two halves of the DNA binding domain being brought closer
together and to abolish any protein-protein interactions involving the
double-turn region. The in vivo function of Rap1p
423-435 was tested
by using strain SCR101. Transformants expressing this mutant version of
Rap1p were unable to grow on glu medium (Fig. 5A). To investigate why
this derivative was nonfunctional, we tested the effect of the deletion
on DNA binding activity in vitro (Fig.
6). Equal amounts of Rap1p containing
either the mutant or wild-type DNA binding domain were tested for
binding to a strong Rap1p binding site (TEF2) and two weaker binding
sites isolated previously when Rap1p was used to select binding sites
from a random pool of oligonucleotides (19).
Rap1p
423-435 bound less strongly to the TEF2 binding site than did
the wild-type Rap1p. Binding of the mutant protein to either of the two
weaker binding sites was not detected. We concluded that the
double-turn deletion mutation abolished Rap1p function in vivo because
the affinity of Rap1p for its binding site was reduced.
|
Domain swap experiments. Another region that could be involved in additional functions is the large unstructured loop within the second Myb-like subdomain. This was found to be relatively poorly conserved between the Rap1p homologues, allowing us to test a range of mutations by swapping domains between the different homologues and the S. cerevisiae protein. Previous workers have shown that the whole K. lactis RAP1 gene cannot complement a defect in the S. cerevisiae RAP1 gene (31), a result confirmed in our test system (data not shown). The region encoding the unstructured loop plus helices 2A and 2B from each of the three budding-yeast RAP1 genes was used to replace precisely the corresponding region of the S. cerevisiae gene. The hybrid genes were then tested for their ability to complement a RAP1 deficiency in SCR101 (Fig. 5B). All three hybrid genes allowed good growth of the strain on glucose medium. When each of the hybrid proteins was synthesized in vitro, each was able to bind strongly and specifically to the TEF2 Rap1p binding site in gel retardation assays (data not shown). These experiments confirmed that even big changes within the unstructured loop region of Rap1p are tolerated without compromising the function of the protein. Since differences in the unstructured loop region could not account for the failure of K. lactis Rap1p to function in S. cerevisiae, we tested the effect of replacing the whole of subdomain 2 of the S. cerevisiae protein with the corresponding subdomain from the K. lactis protein (Fig. 5B). The hybrid protein complemented the RAP1 deficiency in SCR101, although the cells grew significantly more slowly than when wild-type Rap1p was present. We also tested the ability of the complete DNA binding domain of the K. lactis protein to replace the function of the same domain of the S. cerevisiae protein. Complementation experiments demonstrated that this hybrid protein was functional, although, again, growth was compromised significantly (data not shown).
| |
DISCUSSION |
|---|
|
|
|---|
Functional analysis in vivo has demonstrated that the C terminus
of Rap1p is not essential for vegetative growth, despite being the
target for all of the protein-protein interactions involving Rap1p
characterized to date (21, 38, 53). This observation was
confirmed in two test systems, one involving functional complementation of a galactose-repressible RAP1 gene and the other involving
sporulation and growth of a rap1
C strain. The C terminus
contains the putative transcriptional activation domain
(20), deletion of which also resulted in slow growth. It was
known previously that neither the silencing nor the telomere function
of Rap1p is essential for cell growth, and so it was assumed that the
transcriptional activation function of Rap1p is essential (30,
49). Our data suggest either that this is not the case or that
the previously mapped activation domain is not necessary for
transcriptional activation in all contexts. We investigated this by
measuring the mRNA levels of a sample of genes activated by Rap1p in
strains containing Rap1p lacking either the activation or the silencing domain. Interpretation of these experiments is complicated by the fact
that the strains grew more slowly than the wild type and that
expression of the genes that we tested can be influenced by the growth
rate (10, 28). Nevertheless, the results demonstrated clearly that the activation domain of Rap1p is more important in some
contexts than in others. The Mat
UAS is a bidirectional UAS consisting of a single Rap1p binding site, located in the region
between the divergently transcribed MAT
1 and
MAT
2 genes (16). We found that the activation
domain of Rap1p is important at this UAS but that its deletion affected
MAT
1 more severely than it affected MAT
2.
This may be because there is a directionality to the way that Rap1p
functions in this context. Rap1p sites in UAS are usually orientated
with the AC-rich strand running in the 5' to 3' direction towards the
transcription start site. The site in the MAT
intergenic
region is orientated in this way with respect to the MAT
2
gene, and expression of this gene is higher than that of
MAT
1. Perhaps deletion of the activation domain had more
effect on MAT
1 because Rap1p was in a suboptimal position with respect to the basal promoter. Deletion of the silencing domain
resulted in increased levels of mRNA from these genes, probably as a
result of partial derepression of the silenced copies at the
HML locus. Expression of the RPL19 ribosomal
protein genes increased in both deletion strains. This was probably a
secondary consequence of the Rap1p deletions, because it was also
observed for RPL45, a gene that is activated by Abf1p, not
Rap1p (18). Despite this complication, the results show
clearly that the activation domain of Rap1p is not essential for
high-level gene expression in the context of ribosomal protein gene
promoters. The two glycolytic genes tested, PGK and
PYK1, were chosen because the involvement of Rap1p at their
UAS has been well characterized (10, 15, 40). PGK
expression was reduced in both deletion strains, perhaps as a secondary
consequence of growth rate changes. However, there was little
difference between the activation domain and silencing-domain deletion
strains, suggesting that either both or neither of these domains is
important in transcriptional activation of PGK.
PYK1 expression was only mildly affected in both deletion
strains, perhaps because expression of this gene is less susceptible to growth rate effects. The small decrease in expression in the activation domain deletion strain indicates that the activation domain could play
some role in transcriptional activation at this UAS, but again it is
not essential for high-level gene expression.
The data on gene expression and functional complementation by deletion derivatives of Rap1p are consistent with the idea that there is some redundancy of function between the C terminus of Rap1p and other domains of the protein (33). This may include redundancy in both the interaction with Gcr1p and other possible roles in transcriptional activation. In the light of these observations, we focused on the possibility of additional functions for the central DNA binding domain. This is a large region of the protein that could be involved in protein-protein interactions that have not yet been characterized (24, 27). The double-turn motif between the two subdomains appeared to be a good candidate for involvement in such an interaction. Site-directed mutagenesis of two conserved amino acid residues failed to affect the function of Rap1p in vivo, suggesting that this motif is unlikely to be a target for specific protein-protein interactions. Deletion of the double-turn region did affect Rap1p function in vivo, probably as a consequence of an effect on the DNA binding properties of Rap1p. Interestingly, even this big perturbation of the domain did not completely abolish the ability of Rap1p to interact with a strongly recognized target site. In addition to the double-turn region, a second potential target for protein-protein interactions is the large region in the second subdomain described as the unstructured loop (27). The domain swap experiments with different combinations of subelements from the DNA binding domains of Rap1p homologues demonstrated that even big changes within the unstructured loop of the S. cerevisiae protein do not prevent Rap1p function in vivo. Of the 54 amino acids in this region, 30 are different between the S. cerevisiae and K. lactis proteins, but the hybrid protein was still functional. This suggests that the unstructured loop is unlikely to play a key role in any additional functions of the DNA binding domain. Taken together, these analyses suggest that if the DNA binding domain does have another function, this function is more likely to be a consequence of the DNA binding domain interacting with DNA, perhaps involving DNA bending or untwisting, than of a protein-protein interaction.
The data presented has demonstrated that the activation domain of Rap1p, identified by hybrid protein experiments (20), can be important in the context of the whole protein at authentic UAS. However, Rap1p is not a simple transcription factor, because this activation domain appears to be important at only some of the promoters where Rap1p functions. Our data supports the idea that there is functional redundancy between the C terminus and other regions of Rap1p, including the DNA binding domain. It may be this redundancy that has thwarted previous attempts to understand the transcriptional activation function of this protein.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by a Project Grant from the BBSRC (U.K.) and by the University of Nottingham Research Opportunities Fund. K.A.H. is a M.Phil. student funded by the European Union Social Fund.
We thank Paula Gonçalves, Willem Mager, and Rudi Planta (Amsterdam) for generously providing yeast strain SCR101; Judith Berman (Minnesota) for the anti-Rap1p antibody; Sue Miles for technical assistance; Stuart Ingleston for help with figures; and Paul Sharp for advice on protein alignments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute of Genetics, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom. Phone: 44 115 970 9225. Fax: 44 115 970 9906. E-mail: alistair.chambers{at}nott.ac.uk.
Present address: School of Biological Sciences, Division of
Biochemistry, Royal Holloway, University of London, London, United Kingdom.
Present address: Department of Molecular Biology, National
Institute of Bioscience and Human Technology, Tsukuba-shi, Ibaraki-ken 305-8566, Japan.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Baker, H. V.
1986.
Glycolytic gene expression in Saccharomyces cerevisiae: nucleotide sequence of GCR1, null mutants, and evidence for expression.
Mol. Cell. Biol.
6:3774-3784 |
| 2. |
Baker, H. V.
1991.
GCR1 of Saccharomyces cerevisiae encodes a DNA binding protein whose binding is abolished by mutations in the CTTCC sequence motif.
Proc. Natl. Acad. Sci. USA
88:9443-9447 |
| 3. | Bitter, G. A., K. K. H. Chang, and K. M. Egan. 1991. A multi-component upstream activation sequence of the Saccharomyces cerevisiae glyceraldehyde-3-phosphate dehydrogenase gene promoter. Mol. Gen. Genet. 231:22-32[Medline]. |
| 4. |
Brindle, P. K.,
J. P. Holland,
C. E. Willett,
M. A. Innis, and M. J. Holland.
1990.
Multiple factors bind the upstream activation sites of the yeast enolase genes ENO1 and ENO2: ABF1 protein, like repressor activator protein RAP1, binds cis-acting sequences which modulate repression or activation of transcription.
Mol. Cell. Biol.
10:4872-4885 |
| 5. | Butler, G., I. W. Dawes, and D. J. McConnell. 1990. TUF factor binds to the upstream region of the pyruvate decarboxylase structural gene (PDC1) of Saccharomyces cerevisiae. Mol. Gen. Genet. 223:449-456[Medline]. |
| 6. | Callebaut, I., and J. P. Mornon. 1997. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400:25-30[Medline]. |
| 7. | Chambers, A., E. A. Packham, and I. R. Graham. 1995. Control of glycolytic gene expression in the budding yeast (Saccharomyces cerevisiae). Curr. Genet. 29:1-9[Medline]. |
| 8. |
Chambers, A.,
C. Stanway,
A. J. Kingsman, and S. M. Kingsman.
1988.
The UAS of the yeast PGK gene is composed of multiple functional elements.
Nucleic Acids Res.
16:8245-8260 |
| 9. |
Chambers, A.,
C. Stanway,
J. S. H. Tsang,
Y. Henry,
A. J. Kingsman, and S. M. Kingsman.
1990.
ARS binding factor 1 binds adjacent to RAP1 at the UASs of the yeast glycolytic genes PGK and PYK1.
Nucleic Acids Res.
18:5393-5399 |
| 10. |
Chambers, A.,
J. H. Tsang,
C. Stanway,
A. J. Kingsman, and S. M. Kingsman.
1989.
Transcriptional control of the Saccharomyces cerevisiae PGK gene by RAP1.
Mol. Cell. Biol.
9:5516-5524 |
| 11. | Chen, D.-Z., B. C. Yang, and T. T. Kuo. 1992. One-step transformation of yeast in stationary phase. Curr. Genet. 21:83-84[Medline]. |
| 12. |
Clifton, D., and D. G. Fraenkel.
1981.
The gcr (glycolysis regulation) mutation of Saccharomyces cerevisiae.
J. Biol. Chem
256:13074-13078 |
| 13. | Conrad, M. N., J. H. Wright, A. J. Wolf, and V. A. Zakian. 1990. RAP1 protein interacts with yeast telomeres in vivo: overproduction alters telomere structure and decreases chromosome stability. Cell 63:739-750[Medline]. |
| 14. | Devlin, C., K. Tice-Baldwin, D. Shore, and K. T. Arndt. 1991. RAP1 is required for BAS1/BAS2- and GCN4-dependent transcription of the yeast HIS4 gene. Mol. Cell. Biol. 7:3642-3651. |
| 15. | Drazinic, C. M., J. B. Smerage, M. C. Lopez, and H. V. Baker. 1996. Activation mechanism of the multifunctional transcription factor repressor-activator protein 1 (Rap1). Mol. Cell. Biol. 16:3187-3196[Abstract]. |
| 16. |
Giesman, D.,
L. Best, and K. Tatchell.
1991.
The role of RAP1 in the regulation of the Mat locus.
Mol. Cell. Biol.
11:1069-1079 |
| 17. |
Gonçalves, P. M.,
G. Griffioen,
R. Minnee,
M. Bosma,
L. S. Kraakman,
W. H. Mager, and R. J. Planta.
1995.
Transcriptional activation of yeast ribosomal protein genes requires additional elements apart from binding sites for Abf1p or Rap1p.
Nucleic Acids Res.
23:1475-1480 |
| 18. | Gonçalves, P. M., K. Maurer, G. V. N. Amerongen, K. Bergkamp-Steffens, W. H. Mager, and R. J. Planta. 1996. C-terminal domains of general regulatory factors Abf1p and Rap1p in Saccharomyces cerevisiae display functional similarity. Mol. Microbiol. 19:535-543[Medline]. |
| 19. |
Graham, I. R., and A. Chambers.
1994.
Use of a selection technique to identify the diversity of binding sites for the yeast RAP1 transcription factor.
Nucleic Acids Res.
22:124-130 |
| 20. |
Hardy, C. F. J.,
D. Balderes, and D. Shore.
1992.
Dissection of a carboxy-terminal region of the yeast regulatory protein RAP1 with effects on both transcriptional activation and silencing.
Mol. Cell. Biol.
12:1209-1217 |
| 21. |
Hardy, C. F. J.,
L. Sussel, and D. Shore.
1992.
A RAP1-interacting protein involved in transcriptional silencing and telomere length regulation.
Genes Dev.
6:801-814 |
| 22. |
Hawthorne, D. C., and R. K. Mortimer.
1960.
Chromosome mapping in Saccharomyces cerevisiae: centromere-linked genes.
Genetics
45:1085-1110 |
| 23. | Hecht, A., S. Strahl-Bolsinger, and M. Grunstein. 1996. Spreading of transcriptional repressor SIR3 from telomeric heterochromatin. Nature 383:92-95[Medline]. |
| 24. |
Henry, Y. A. L.,
A. Chambers,
J. S. H. Tsang,
A. J. Kingsman, and S. M. Kingsman.
1990.
Characterisation of the DNA binding domain of the yeast RAP1 protein.
Nucleic Acids Res.
18:2617-2623 |
| 25. | Hoffman, C. S., and F. Winston. 1987. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 57:267-272[Medline]. |
| 26. |
Holland, M. J.,
T. Yokoi,
J. P. Holland,
K. Myambo, and M. A. Innis.
1987.
The GCR1 gene encodes a positive transcriptional regulator of the enolase and glyceraldehyde-3-phosphate dehydrogenase gene families in Saccharomyces cerevisiae.
Mol. Cell. Biol.
7:813-820 |
| 27. | Konig, P., R. Giraldo, L. Chapman, and D. Rhodes. 1996. The crystal structure of the DNA-binding domain of yeast RAP1 in complex with telomeric DNA. Cell 85:125-136[Medline]. |
| 28. | Kraakman, L. S., G. Griffioen, S. Zerp, P. Groeneveld, J. M. Thevelein, W. M. Mager, and R. J. Planta. 1993. Growth-related expression of ribosomal protein genes in Saccharomyces cerevisiae. Mol. Gen. Genet. 238:196-204. |
| 29. |
Kurtz, S., and D. Shore.
1991.
RAP1 protein activates and silences transcription of mating-type genes in yeast.
Genes Dev.
5:616-628 |
| 30. |
Kyrion, G.,
K. A. Boakye, and A. J. Lustig.
1992.
C-terminal truncation of RAP1 results in the deregulation of telomere size, stability, and function in Saccharomyces cerevisiae.
Mol. Cell. Biol.
12:5159-5173 |
| 31. | Larson, G. P., D. Castanotto, J. J. Rossi, and M. P. Malafa. 1994. Isolation and functional analysis of a Kluyveromyces lactis RAP1 homologue. Gene 150:35-41[Medline]. |
| 32. | Liu, C., X. Mao, and A. J. Lustig. 1994. Mutational analysis defines a C-terminal tail domain of RAP1 essential for telomeric silencing in Saccharomyces cerevisiae. Genetics 138:1025-1040[Abstract]. |
| 33. |
Lopez, M. C.,
J. B. Smerage, and H. V. Baker.
1998.
Multiple domains of repressor activator protein 1 contribute to facilitated binding of glycolysis regulatory protein 1.
Proc. Natl. Acad. Sci. USA
95:14112-14117 |
| 34. |
Lustig, A. J.,
S. Kurtz, and D. Shore.
1990.
Involvement of the silencer and UAS binding protein RAP1 in regulation of telomere length.
Science
250:549-553 |
| 35. |
Marcand, S.,
E. Gilson, and D. Shore.
1997.
A protein-counting mechanism for telomere length regulation in yeast.
Science
275:986-990 |
| 36. | Mellor, J., M. J. Dobson, N. A. Roberts, M. F. Tuite, J. S. Emtage, S. White, P. A. Lowe, T. Patel, A. J. Kingsman, and S. M. Kingsman. 1983. Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae. Gene 24:1-14[Medline]. |
| 37. |
Mizuta, K.,
R. Tsujii,
J. R. Warner, and M. Nishiyama.
1998.
The C-terminal silencing domain of Rap1p is essential for the repression of ribosomal protein genes in response to a defect in the secretory pathway.
Nucleic Acids Res.
26:1063-1069 |
| 38. |
Moretti, P.,
K. Freeman,
L. Coodly, and D. Shore.
1994.
Evidence that a complex of SIR proteins interacts with the silencer and telomere binding protein RAP1.
Genes Dev.
8:2257-2269 |
| 39. | Muller, T., E. Gilson, R. Schmidt, R. Giraldo, J. Sogo, H. Gross, and S. M. Gasser. 1994. Imaging the asymmetrical DNA bend induced by repressor activator protein 1 with scanning tunneling microscopy. J. Struct. Biol. 113:1-12[Medline]. |
| 40. |
Nishizawa, M.,
R. Araki, and Y. Teranishi.
1989.
Identification of an upstream activating sequence and an upstream repressible sequence of the pyruvate kinase gene of the yeast Saccharomyces cerevisiae.
Mol. Cell. Biol.
9:442-451 |
| 41. |
Ogden, J. E.,
C. Stanway,
S. Kim,
J. Mellor,
A. J. Kingsman, and S. M. Kingsman.
1986.
Efficient expression of the Saccharomyces cerevisiae PGK gene depends on an upstream activating sequence, but does not require TATA sequences.
Mol. Cell. Biol.
6:4335-4343 |
| 42. | Pretorius, G. H. J., and H. E. Muller. 1992. Conservation of binding site specificity of three yeast DNA binding proteins. FEBS Lett. 298:203-205[Medline]. |
| 43. |
Rotenberg, M. O., and J. R. Woolford.
1986.
Tripartite upstream promoter element essential for expression of Saccharomyces cerevisiae ribosomal protein genes.
Mol. Cell. Biol.
6:674-687 |
| 44. |
Santangelo, G. M., and J. Tornow.
1990.
Efficient transcription of the glycolytic gene ADH1 and three translational component genes requires the GCR1 product, which can act through TUF/GRF/RAP binding sites.
Mol. Cell. Biol.
10:859-862 |
| 45. | Sherman, F. 1991. Getting started with yeast. Methods Enzymol. 194:3-21[Medline]. |
| 46. | Shore, D. 1994. RAP1: a protean regulator in yeast. Trends Genet. 10:408-412[Medline]. |
| 47. | Shore, D., and K. Nasmyth. 1987. Purification and cloning of a DNA binding protein from yeast that binds to both silencer and activator elements. Cell 51:721-732[Medline]. |
| 48. |
Sikorski, R. S., and P. Hieter.
1989.
A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae.
Genetics
122:19-27 |
| 49. |
Sussel, L., and D. Shore.
1991.
Separation of transcriptional activation and silencing functions of the RAP1-encoded repressor/activator protein 1: isolation of viable mutants affecting both silencing and telomere length.
Proc. Natl. Acad. Sci. USA
88:7749-7753 |
| 50. |
Thompson, J. D.,
J. D. Higgins, and T. J. Gibson.
1994.
Clustal-W-improving the sensitivity of progressive multiple sequence alignment through sequence weighting position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 51. | Tornow, J., X. Zeng, W. Gao, and G. M. Santangelo. 1993. GCR1, a transcriptional activator in Saccharomyces cerevisiae, complexes with RAP1 and can function without its DNA binding domain. EMBO J. 12:2431-2437[Medline]. |
| 52. | Uemura, H., M. Koshio, Y. Inoue, M. Cecilia Lopez, and H. V. Baker. 1997. The role of Gcr1p in the transcriptional activation of glycolytic genes in yeast Saccharomyces cerevisiae. Genetics 147:521-532[Abstract]. |
| 53. |
Wotton, D., and D. Shore.
1997.
A novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae.
Genes Dev.
11:748-760 |
| 54. |
Woudt, L. P.,
W. H. Mager,
R. T. M. Nieuwint,
G. M. Wassenaar,
A. C. van der Kuyl,
J. J. Murre,
M. F. M. Hoekman,
P. G. M. Brockhoff, and R. J. Planta.
1987.
Analysis of upstream activation sites of yeast ribosomal protein genes.
Nucleic Acids Res.
15:6037-6048 |